Cadence Bank NA’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-8,178
| Closed | -$445K | – | 99 |
|
|
2022
Q2 | $445K | Hold |
8,178
| – | – | 0.14% | 134 |
|
|
2022
Q1 | $445K | Hold |
8,178
| – | – | 0.12% | 139 |
|
|
2021
Q4 | $451K | Hold |
8,178
| – | – | 0.12% | 139 |
|
|
2021
Q3 | $391K | Buy |
8,178
+63
| +0.8% | +$3.01K | 0.12% | 143 |
|
|
2021
Q2 | $404K | Hold |
8,115
| – | – | 0.12% | 145 |
|
|
2021
Q1 | $362K | Buy |
8,115
+80
| +1% | +$3.57K | 0.11% | 154 |
|
|
2020
Q4 | $370K | Sell |
8,035
-9,484
| -54% | -$437K | 0.13% | 140 |
|
|
2020
Q3 | $824K | Buy |
17,519
+1,073
| +7% | +$50.5K | 0.32% | 79 |
|
|
2020
Q2 | $839K | Buy |
16,446
+647
| +4% | +$33K | 0.35% | 73 |
|
|
2020
Q1 | $748K | Buy |
15,799
+5,820
| +58% | +$276K | 0.38% | 69 |
|
|
2019
Q4 | $586K | Buy |
9,979
+2,111
| +27% | +$124K | 0.22% | 115 |
|
|
2019
Q3 | $420K | Buy |
7,868
+155
| +2% | +$8.27K | 0.16% | 130 |
|
|
2019
Q2 | $386K | Buy |
7,713
+21
| +0.3% | +$1.05K | 0.15% | 138 |
|
|
2019
Q1 | $401K | Sell |
7,692
-117
| -1% | -$6.1K | 0.16% | 129 |
|
|
2018
Q4 | $373K | Buy |
+7,809
| New | +$373K | 0.17% | 122 |
|
|
2017
Q3 | – | Sell |
-4,369
| Closed | -$236K | – | 176 |
|
|
2017
Q2 | $236K | Sell |
4,369
-753
| -15% | -$40.7K | 0.11% | 124 |
|
|
2017
Q1 | $269K | Sell |
5,122
-1,903
| -27% | -$99.9K | 0.12% | 111 |
|
|
2016
Q4 | $339K | Sell |
7,025
-21
| -0.3% | -$1.01K | 0.16% | 97 |
|
|
2016
Q3 | $380K | Sell |
7,046
-38
| -0.5% | -$2.05K | 0.17% | 87 |
|
|
2016
Q2 | $384K | Buy |
7,084
+1,202
| +20% | +$65.2K | 0.19% | 87 |
|
|
2016
Q1 | $298K | Buy |
+5,882
| New | +$298K | 0.15% | 103 |
|
|
2015
Q4 | – | Sell |
-4,360
| Closed | -$210K | – | 137 |
|
|
2015
Q3 | $210K | Buy |
4,360
+281
| +7% | +$13.5K | 0.12% | 118 |
|
|
2015
Q2 | $212K | Buy |
+4,079
| New | +$212K | 0.14% | 120 |
|